🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the corporations withheld safety concerns that the medication presented to children's neurological development.

This legal action arrives a month after President Donald Trump promoted an unproven link between using acetaminophen - alternatively called acetaminophen - throughout gestation and autism in children.

Paxton is filing suit against J&J, which once produced the medication, the only pain reliever approved for pregnant women, and Kenvue, which presently makes it.

In a official comment, he said they "deceived the public by gaining financially from discomfort and promoting medication without regard for the risks."

The manufacturer states there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These manufacturers lied for decades, knowingly endangering countless individuals to line their pockets," Paxton, a Republican, declared.

Kenvue commented that it was "very worried by the perpetuation of misinformation on the safety of acetaminophen and the likely effects that could have on the health of US mothers and children."

On its official site, Kenvue also mentioned it had "continuously evaluated the relevant science and there is no credible data that demonstrates a established connection between using paracetamol and autism spectrum disorder."

Associations speaking for doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has said paracetamol - the primary component in acetaminophen - is one of the few options for women during pregnancy to treat discomfort and elevated temperature, which can pose significant medical dangers if left untreated.

"In multiple decades of studies on the consumption of paracetamol in gestation, not a single reputable study has successfully concluded that the consumption of paracetamol in any trimester of pregnancy results in neurodevelopmental disorders in children," the group said.

The lawsuit references recent announcements from the former administration in asserting the drug is reportedly hazardous.

Recently, Trump caused concern from public health officials when he instructed women during pregnancy to "struggle intensely" not to use acetaminophen when unwell.

Federal regulators then published an announcement that doctors should consider limiting the use of Tylenol, while also mentioning that "a proven link" between the drug and autism in young ones has remains unverified.

The Health Department head Robert F Kennedy Jr, who supervises the Food and Drug Administration, had pledged in April to undertake "a massive testing and research effort" that would identify the source of autism spectrum disorder in a limited time.

But authorities advised that identifying a single cause of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of inherited and external influences - would be difficult.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that influences how persons perceive and relate to the environment, and is diagnosed using doctors' observations.

In his court filing, Paxton - aligned with the former president who is campaigning for US Senate - asserts the manufacturer and Johnson & Johnson "intentionally overlooked and attempted to silence the research" around acetaminophen and autism.

The lawsuit seeks to make the companies "destroy any commercial messaging" that asserts acetaminophen is reliable for pregnant women.

The court case mirrors the grievances of a assembly of guardians of young ones with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in 2022.

A federal judge rejected the lawsuit, stating studies from the family's specialists was lacking definitive proof.